JOHN NEIS - 28 Jun 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for John Neis
Issuer symbol
CLRB
Transactions as of
28 Jun 2023
Net transactions value
$0
Form type
4
Filing time
28 Jun 2023, 18:26:14 UTC
Previous filing
01 Aug 2022
Next filing
18 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +25,000 +109% $0.000000 47,887 28 Jun 2023 Common Stock 25,000 $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date.